The National Cancer Policy Forum will hold a workshop to examine the social determinants of health in the context of cancer, and to consider opportunities to effectively leverage big data to improve health equity and reduce disparities.

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium is accepting applications for their Cancer Drug Discovery Data Scientist Fellowship program. This virtual information session will give potential applicants an opportunity to ask questions about the fellowship program and the application process.

The Human Genome Project was launched with the promise of revealing all of our genes, the “code” that would help explain our biology. The publication of the human genome in 2001 provided only a very rough answer to this question. For more than a decade following, the number of protein-coding genes steadily shrank, but the introduction of RNA sequencing revealed a vast new world of splice variants and RNA genes. Dr. Salzberg will review where we’ve been and where we are today, and will describe the use of an unprecedentedly large RNA sequencing resource to create a comprehensive new human gene catalog, containing thousands of novel genes and gene variants.

Dr. Savova and Dr. Hochheiser will describe the DeepPhe system for extracting rich cancer phenotypes and its visual analytics platform.

The National Cancer Institute’s Office of Cancer Clinical Proteomics Research (OCCPR) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) is pleased to announce the 2019 CPTAC Symposium, which offers an exciting opportunity to learn about the field of cancer proteogenomics and the strides in cancer research made by CPTAC investigators. 

The Accelerating Therapeutics for Opportunities in Medicine (ATOM) Consortium is accepting applications for their Cancer Drug Discovery Data Scientist Fellowship program. This virtual information session will give potential applicants an opportunity to ask questions about the fellowship program and the application process.

NCI will host a webinar on October 8 to share updates regarding the Childhood Cancer Data Initiative (CCDI).

Dr. Adeyemo from the National Human Genome Research Institute (NHGRI) and Dr. Hull from the NIH Clinical Center will describe the potential advantages and disadvantages of ancestry testing as a surrogate for race and discuss the ethics of adopting such a practice in cancer research.

This workshop is intended to strengthen and expand NIH's innovation ecosystem by engaging researchers, practitioners, and other professionals interested in artificial intelligence healthcare across the nation's academic and industrial bases.

This webinar is intended for cancer researchers and bioinformaticians who are interested in learning more about the NCI Genomic Data Commons (GDC) bioinformatics pipelines supporting data harmonization.